Position in PFE
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$3,888,727
-$587,112 QoQ
Shares Held
161,492
+1.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#701
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Jun 30, 2024CallValue
$279,800
CallShares
10,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Venture Visionary Partners LLC holds $76,580,519 across 12 Drug Manufacturers - General names. PFE ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,155 | $16,977,933 | |
| 2 | JNJ |
Johnson & Johnson
|
65,476 | $16,628,939 | |
| 3 | AMGN |
Amgen Inc
|
42,758 | $15,483,526 | |
| 4 | ABBV |
AbbVie Inc.
|
38,688 | $9,735,448 | |
| 5 | MRK |
Merck & Co., Inc.
|
45,543 | $5,852,275 | |
| 6 | PFE |
Pfizer Inc
This page
|
161,492 | $3,888,727 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
54,007 | $3,111,883 | |
| 8 | NVS |
Novartis AG
|
9,396 | $1,472,541 |
All Filings in PFE
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,888,727 | 161,492 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $4,475,839 | 159,396 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,956,361 | 158,890 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,679,758 | 183,664 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $4,672,769 | 192,771 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $10,063,679 | 397,146 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $10,012,050 | 377,386 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $12,480,432 | 431,252 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $279,800 | 10,000 | Call | Sole | 2024-08-13 | |
| 2024-06-30 | $11,831,818 | 422,867 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $277,500 | 10,000 | Call | Sole | 2024-05-13 | |
| 2024-03-31 | $8,462,140 | 304,942 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $431,850 | 15,000 | Call | Sole | 2024-02-15 | |
| 2023-12-31 | $8,175,640 | 283,975 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $9,496,969 | 286,312 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $10,511,277 | 286,567 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $11,612,740 | 284,626 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $14,037,300 | 273,952 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $11,406,262 | 260,655 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,307,625 | 253,817 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $12,553,551 | 242,487 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $13,224,838 | 223,960 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $9,243,150 | 214,907 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $7,177,205 | 183,279 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $5,751,802 | 158,758 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $4,535,617 | 123,217 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $1,713,668 | 46,694 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $913,508 | 27,936 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $911,731 | 27,933 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||